Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135022) titled 'Clinical intervention study on the regulation of glucose and lipid metabolism disorders based on gut microbiota modulation' on Oct. 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shandong First Medical University Affiliated Provincial Hospital (Shandong Provincial Hospital)
Condition:
Metabolic risk diseases
Intervention:
Experimental group:Probiotic Li05 + Lifestyle Intervention
Recruitment Status: Recruiting
Phase: 3
Date of First Enrollment: 2025-11-08
Target Sample Size: Experimental group:60;Control group:60;
Countries of Recruitment:
China
To know more, visit ht...